In sickle cell disease, the abnormal polymerization of hemoglobin S leads to hemolysis and blockage of small blood vessels, contributing to complications like acute chest syndrome.
Researchers used advanced imaging techniques on SCD mice and blood samples to investigate the role of the immune system in causing lung vasoocclusion and injury.
They found that platelet activation linked to an inflammasome response results in the formation of inflammatory molecules and platelet-neutrophil aggregates that hinder blood flow, suggesting new therapeutic targets could help prevent acute chest syndrome.
This study investigates how sickle cell disease (SCD) causes blockages in lung blood vessels, leading to lung injuries during crises.
Researchers used advanced imaging in mice with SCD and found that neutrophils and platelets form clumps that block tiny lung arteries and worsen the condition.
Targeting specific molecules on platelets may offer a new treatment approach to prevent lung complications in SCD patients by reducing these harmful aggregates.